摘要
目的:观察研究玻璃体腔注射膨胀气体全氟丙烷(C3F8)治疗玻璃体黄斑牵引综合征的疗效。方法:回顾分析12例12眼玻璃体黄斑牵引综合征患者玻璃体腔注射0.3mLC3F8后1mo玻璃体黄斑牵拉情况以及最佳矫正视力、黄斑中心神经上皮厚度的变化情况。结果:玻璃体黄斑牵拉状态完全解除5眼(42%)。治疗前后患者平均视力分别为0.20±0.07,0.25±0.04。黄斑中心神经上皮最大厚度平均减少69μm。结论:玻璃体腔注射C3F8是一种治疗玻璃体黄斑牵引综合征的有效方法,并且与玻璃体切除手术相比较创伤更小、安全性更高。
AIM： To study the efficacy of a single intravitreal injection of perfluoropropane （ C3F8 ） in releasing vitreomacular traction. METHODS： Twelve eyes of 12 consecutive patients with vitreomacular traction received a single intravitreal injection of 0. 3mL 100% （ C3 F8） were retrospectively analyzed. The best corrected vision acuity and the neural epithelium thickness of central macular were observed. RESULTS： One month following treatment, vitreomacular traction was released in 5 eyes （42%）, mean final visual acuity （VA） improved 0.04 and mean central foveal thickness decreased by 691m. The vision acuity before and after treatment were 0.20±0.07, 0.25± 0.04 respectively. CONCLUSION： Intravitreal C3 F8 injection could offer a minimally invasive alternative to pars plana vitrectomy in patients with vitreomacular traction.
出处
《国际眼科杂志》
CAS
2013年第7期1485-1486,共2页
International Eye Science
